Tao, Pan,
Galiullin, D,
Chen, X.L.,
Zhang, W.H.,
Yang, K,
Liu, K,
Zhao, L.Y.,
Chen, X.Z.,
Hu, J.K. (2021) . The performance of the
model was assessed with its discrimination, calibration, and clinical usefulness. A total
YANG, G.,
SUN, J.,
ZHANG, D.,
ZHANG, R.,
ZHONG, Y.,
WANG, X.,
CHEN, X.,
LIU, B.,
LI, L.,
ZHAO, S.,
WANG, L.,
YUAN, C.,
LONG, M.,
JIANG, H.,
LI, C.,
ZHOU, Q.,
LIAN, A.,
GAREEV, I. (2020) was defined by the modified Rankin Scale and mortality at
3 months. The associations between LVEF and outcome
Ye, L.,
Chen, X.,
Wang, M.,
Jin, L.,
Zhuang, Z.,
Yang, D.,
Guan, X.,
Samorodov, A.V.,
Pavlov, V.N.,
Chattipakorn, N.,
Feng, J.,
Wang, Y.,
Luo, W.,
Liang, G. (2021) -induced cardiomyopathy by suppressing JNK-mediated inflammation. High-fat diet (HFD)-induced obesity mouse
modelYANG, G.,
LIU, Z.,
CHEN, X.,
WANG, X.,
ZHANG, D.,
YANG, Z.,
SUN, J.,
XUE, L.,
GAO, M.,
LI, L.,
GAREEV, I.,
ZHAO, S.,
WANG, L.,
DONG, Q.,
ZHOU, Q.,
YI, R.,
AI, J. (2019) , neurological score, and levels of miR-195 and CX
3CL1/CX
3CR1 mRNA and protein expression were assessed in mice
LIU, Z.,
ZHANG, R.,
CHEN, X.,
YAO, P.,
YAN, T.,
LIU, W.,
YAO, J.,
ZHAO, S.,
SOKHATSKII, A.,
GAREEV, I. (2019) by RT-qPCR on the rat ICH
model.
Result
A total of 59 up-regulated genes and eight down-regulated genes
Pang, H.Y.,
Chen, X.L.,
Song, X.H.,
Galiullin, D.,
Zhao, L.Y.,
Liu, K,
Zhang, W.H.,
Yang, K,
Chen, X.Z.,
Hu, J.K. (2021) was the incidence of AL. The analysis was performed using RevMan v5.
3 and Stata v12.0 software. Results: Eighteen
Luo, W.,
Chen, X.,
Ye, L.,
Chen, X.,
Jia, W.,
Zhao, Y.,
Samorodov, A.V.,
Zhang, Y.,
Hu, X.,
Zhuang, F.,
Qian, J.,
Zheng, C.,
Liang, G.,
Wang, Y. (2021) rhizome, with anti-oxidant/anti-inflammatory effects demonstrated in various disease
models, including
YUE, E.,
TUGUZBAEVA, G.M.,
CHEN, X.,
LI, A.,
SUN, X.,
DONG, C.,
LIU, Y.,
YU, Y.,
ZAHRA, S.M.,
JIANG, Y.,
BAI, Y.,
QIN, Y.,
SHAN, Q.,
DU, Z. (2019) -binding oligomerization domain-like receptor pyrin domain containing
3 (NLRP
3), caspase-1 and IL-1β were detected using q
Pang, H.-Y.,
Zhao, L.-Y,
Zhang, Z.-Q,
Galiullin, D.,
Chen, X.-L.,
Liu, K.,
Zhang, W.-H.,
Yang, K.,
Chen, X.-Z.,
Hu, J.-K. (2021) rate. The
3-year overall survival (OS) rate was not significant different in the LG and OG groups (66